2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide

C113H130N24O20 — CID 165049208

IUPAC2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide
SMILESCOc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ccon2)NC(=O)CN(C)C)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)C23CCN(CC2)CC3)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)C2CC23CCN(C)CC3)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)CN(C)C)[nH]1
InChIInChI=1S/C31H36N6O5.C30H34N6O5.2C26H30N6O5/c1-37-12-9-31(10-13-37)17-22(31)28(39)35-25(19-41-14-5-8-26(38)30-32-11-15-42-30)27-33-18-24(34-27)21-16-20-6-3-4-7-23(20)36-29(21)40-2;1-39-27-21(17-20-5-2-3-6-22(20)34-27)23-18-32-26(33-23)24(19-40-15-4-7-25(37)28-31-11-16-41-28)35-29(38)30-8-12-36(13-9-30)14-10-30;1-32(2)15-23(34)29-21(16-36-11-6-9-22(33)26-27-10-12-37-26)24-28-14-20(30-24)18-13-17-7-4-5-8-19(17)31-25(18)35-3;1-32(2)15-24(34)28-22(16-36-11-6-9-23(33)20-10-12-37-31-20)25-27-14-21(29-25)18-13-17-7-4-5-8-19(17)30-26(18)35-3/h3-4,6-7,11,15-16,18,22,25H,5,8-10,12-14,17,19H2,1-2H3,(H,33,34)(H,35,39);2-3,5-6,11,16-18,24H,4,7-10,12-15,19H2,1H3,(H,32,33)(H,35,38);4-5,7-8,10,12-14,21H,6,9,11,15-16H2,1-3H3,(H,28,30)(H,29,34);4-5,7-8,10,12-14,22H,6,9,11,15-16H2,1-3H3,(H,27,29)(H,28,34)/t22?,25-;24-;21-;22-/m0000/s1
InChIKeyPJYCTDCJHZLZJA-YEMOPQHMSA-N
MW2144.43 g/mol
LogP14.18
Rot. Bonds50

About 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide

2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide (PubChem CID 165049208) has the molecular formula C113H130N24O20 and a molecular weight of 2144.43 g/mol. Its IUPAC name is 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide.

Molecular Properties

Compound Name2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide
PubChem CID165049208
Molecular FormulaC113H130N24O20
Molecular Weight2144.43 g/mol
Exact Mass2142.99
IUPAC Name2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide
SMILESCOc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ccon2)NC(=O)CN(C)C)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)C23CCN(CC2)CC3)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)C2CC23CCN(C)CC3)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)CN(C)C)[nH]1
InChIInChI=1S/C31H36N6O5.C30H34N6O5.2C26H30N6O5/c1-37-12-9-31(10-13-37)17-22(31)28(39)35-25(19-41-14-5-8-26(38)30-32-11-15-42-30)27-33-18-24(34-27)21-16-20-6-3-4-7-23(20)36-29(21)40-2;1-39-27-21(17-20-5-2-3-6-22(20)34-27)23-18-32-26(33-23)24(19-40-15-4-7-25(37)28-31-11-16-41-28)35-29(38)30-8-12-36(13-9-30)14-10-30;1-32(2)15-23(34)29-21(16-36-11-6-9-22(33)26-27-10-12-37-26)24-28-14-20(30-24)18-13-17-7-4-5-8-19(17)31-25(18)35-3;1-32(2)15-24(34)28-22(16-36-11-6-9-23(33)20-10-12-37-31-20)25-27-14-21(29-25)18-13-17-7-4-5-8-19(17)30-26(18)35-3/h3-4,6-7,11,15-16,18,22,25H,5,8-10,12-14,17,19H2,1-2H3,(H,33,34)(H,35,39);2-3,5-6,11,16-18,24H,4,7-10,12-15,19H2,1H3,(H,32,33)(H,35,38);4-5,7-8,10,12-14,21H,6,9,11,15-16H2,1-3H3,(H,28,30)(H,29,34);4-5,7-8,10,12-14,22H,6,9,11,15-16H2,1-3H3,(H,27,29)(H,28,34)/t22?,25-;24-;21-;22-/m0000/s1
InChIKeyPJYCTDCJHZLZJA-YEMOPQHMSA-N
XLogP14.18
TPSA541.88 Ų
H-Bond Donors8
H-Bond Acceptors36
Rotatable Bonds50
Heavy Atoms157
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002144.43
LogP ≤ 514.18
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1036

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide?
The IUPAC name of 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide (CID 165049208) is 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide.
What is the SMILES notation for 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide?
The canonical SMILES for 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide is COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ccon2)NC(=O)CN(C)C)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)C23CCN(CC2)CC3)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)C2CC23CCN(C)CC3)[nH]1.COc1nc2ccccc2cc1-c1cnc([C@H](COCCCC(=O)c2ncco2)NC(=O)CN(C)C)[nH]1.
What is the InChIKey of 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide?
The InChIKey is PJYCTDCJHZLZJA-YEMOPQHMSA-N. The full InChI is InChI=1S/C31H36N6O5.C30H34N6O5.2C26H30N6O5/c1-37-12-9-31(10-13-37)17-22(31)28(39)35-25(19-41-14-5-8-26(38)30-32-11-15-42-30)27-33-18-24(34-27)21-16-20-6-3-4-7-23(20)36-29(21)40-2;1-39-27-21(17-20-5-2-3-6-22(20)34-27)23-18-32-26(33-23)24(19-40-15-4-7-25(37)28-31-11-16-41-28)35-29(38)30-8-12-36(13-9-30)14-10-30;1-32(2)15-23(34)29-21(16-36-11-6-9-22(33)26-27-10-12-37-26)24-28-14-20(30-24)18-13-17-7-4-5-8-19(17)31-25(18)35-3;1-32(2)15-24(34)28-22(16-36-11-6-9-23(33)20-10-12-37-31-20)25-27-14-21(29-25)18-13-17-7-4-5-8-19(17)30-26(18)35-3/h3-4,6-7,11,15-16,18,22,25H,5,8-10,12-14,17,19H2,1-2H3,(H,33,34)(H,35,39);2-3,5-6,11,16-18,24H,4,7-10,12-15,19H2,1H3,(H,32,33)(H,35,38);4-5,7-8,10,12-14,21H,6,9,11,15-16H2,1-3H3,(H,28,30)(H,29,34);4-5,7-8,10,12-14,22H,6,9,11,15-16H2,1-3H3,(H,27,29)(H,28,34)/t22?,25-;24-;21-;22-/m0000/s1.
What are the key properties of 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide?
2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide has a molecular weight of 2144.43 g/mol, XLogP of 14.18, 50 rotatable bonds, 8 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,2-oxazol-3-yl)-4-oxobutoxy]ethyl]acetamide;2-(dimethylamino)-N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]acetamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-1-azabicyclo[2.2.2]octane-4-carboxamide;N-[(1R)-1-[5-(2-methoxyquinolin-3-yl)-1H-imidazol-2-yl]-2-[4-(1,3-oxazol-2-yl)-4-oxobutoxy]ethyl]-6-methyl-6-azaspiro[2.5]octane-2-carboxamide is sourced from PubChem (CID 165049208), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).